nifedipine has been researched along with dihydroergotoxine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brodde, OE; Daul, A; Michel, MC; Mindermann, G | 1 |
Dominiak, P; Weidinger, G | 1 |
Kirsten, R; Nelson, K; Weidinger, G; Welzel, D | 1 |
Janka, HU; Mehnert, H | 1 |
Heintz, B; Heller, A; Kirsten, R; Nelson, K | 1 |
Kerp, L; Khalaf, N; Ortgiese, R; Petersen, KG; Schliebs, B; Schuler, G | 1 |
Demichel, P; Roquebert, J | 1 |
Demichel, P; Gomond, P; Malek, A; Roquebert, J | 1 |
6 trial(s) available for nifedipine and dihydroergotoxine
Article | Year |
---|---|
Effects of antihypertensive therapy on human alpha- and beta-adrenoceptors.
Topics: Dihydroergotoxine; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Norepinephrine; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1991 |
[Therapy comparison between the combination hydergine/nifedipine and nifedipine alone in patients with isolated systolic hypertension].
Topics: Aged; Blood Pressure; Dihydroergotoxine; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Nifedipine | 1991 |
Co-dergocrine mesylate inhibits the increase in plasma catecholamines caused by nifedipine in essential hypertension.
Topics: Aldosterone; Catecholamines; Dihydroergotoxine; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Renin | 1990 |
[Antihypertensive therapy with co-dergocrine mesilate/nifedipine in comparison with nifedipine in type II diabetes].
Topics: Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Dihydroergotoxine; Female; Glycated Hemoglobin; Glycosuria; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine | 1990 |
Influence of co-dergocrine mesilate/nifedipine compared to mefruside/nifedipine on circadian blood pressure in patients with essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Dihydroergotoxine; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Mefruside; Middle Aged; Monitoring, Physiologic; Nifedipine | 1990 |
[Glucose tolerance and electrolyte metabolism in nifedipine and nifedipine dihydroergotoxin treated healthy subjects].
Topics: Adult; C-Peptide; Dihydroergotoxine; Electrolytes; Glucose; Glucose Tolerance Test; Heart Rate; Humans; Insulin; Male; Nifedipine; Norepinephrine; Renin | 1989 |
2 other study(ies) available for nifedipine and dihydroergotoxine
Article | Year |
---|---|
Alpha-adrenergic agonist and antagonist activity of dihydroergotoxine in rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Anesthesia; Animals; Dihydroergotoxine; Electric Stimulation; Heart Rate; Hemodynamics; Male; Methysergide; Nifedipine; Phenylephrine; Prazosin; Rats; Rats, Inbred Strains; Spinal Cord; Yohimbine | 1985 |
Effect of dihydroergocristine on blood pressure and activity at peripheral alpha-adrenoceptors in pithed rats.
Topics: Animals; Blood Pressure; Decerebrate State; Dihydroergotoxine; Dose-Response Relationship, Drug; Electric Stimulation; Heart Rate; Male; Nifedipine; Phenylephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Spinal Cord; Yohimbine | 1984 |